Recent Updates
Recently added Catalysts
CRL Positive Sentiment

Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

Tuesday, September 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Charles River Laboratories has launched its Endosafe® Cartridge Technology Automated Manufacturing Suite, enhancing the production of bacterial endotoxin testing cartridges. This new suite aims to improve in-process inspection, digital traceability, and overall manufacturing controls. The suite is expected to reach full operational capacity by Q3 2026, marking a significant investment in advanced manufacturing technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Implementation of automated manufacturing suite enhances efficiency.
  • Increased production capacity supports growing demand.
  • Strengthened manufacturing controls improve product quality.

Full Press Release Details

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) has successfully implemented its Endosafe® Cartridge Technology Automated Manufacturing Suite, a significant advancement in bacterial endotoxin testing cartridge production that expands in-process inspection and digital traceability, strengthens manufacturing controls and increases production capacity. Reaching full operational capacity in Q3 2026, the automated suite is a major investment in advanced

Frequently Asked Questions

What is the Endosafe® Cartridge Technology?

The Endosafe® Cartridge Technology is used for bacterial endotoxin testing.

When will the automated manufacturing suite be fully operational?

The automated manufacturing suite is expected to reach full operational capacity by Q3 2026.

What improvements does the new manufacturing suite offer?

The suite enhances in-process inspection, digital traceability, and manufacturing controls.

How does automation impact production capacity?

Automation significantly increases production capacity for the Endosafe® cartridges.

ShareAdd on Google
Tags: CRL Viatris Investor Conferences Healthcare Charles River Laboratories Endosafe automated manufacturing bacterial endotoxin testing production capacity
Last updated: Sep 8, 2026

Biotech snapshot

Cash runway
$241M liquidity · $0M/mo burn
Low dilution risk